Us Bancorp \De\ Lantern Pharma Inc. Transaction History

Us Bancorp \De\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.11 - $11.04 $14,220 - $22,080	-2,000 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$14.34 - $21.92 $28,680 - $43,840	2,000 New	2,000 $36,000
Q4 2020 Feb 04, 2021	SELL	$15.1 - $20.69 $3,020 - $4,138	-200 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$11.54 - $14.95 $2,308 - $2,990	200 New	200 $3,000

1.31M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $37M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.